EPS for Amphastar Pharmaceuticals, Inc. (AMPH) Expected At $0.09; Shorts at ERO COPPER ORDINARY SHARES CANADA (ERRPF) Lowered By 3.59%

April 17, 2018 - By Migdalia James

Analysts expect Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) to report $0.09 EPS on May, 14.They anticipate $0.06 EPS change or 200.00% from last quarter’s $0.03 EPS. AMPH’s profit would be $4.17M giving it 54.56 P/E if the $0.09 EPS is correct. After having $0.10 EPS previously, Amphastar Pharmaceuticals, Inc.’s analysts see -10.00% EPS growth. The stock increased 2.40% or $0.46 during the last trading session, reaching $19.64. About 104,309 shares traded. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) has risen 29.43% since April 17, 2017 and is uptrending. It has outperformed by 17.88% the S&P500.

ERO COPPER CORP ORDINARY SHARES CANADA (OTCMKTS:ERRPF) had a decrease of 3.59% in short interest. ERRPF’s SI was 18,800 shares in April as released by FINRA. Its down 3.59% from 19,500 shares previously. With 200 avg volume, 94 days are for ERO COPPER CORP ORDINARY SHARES CANADA (OTCMKTS:ERRPF)’s short sellers to cover ERRPF’s short positions. The SI to ERO COPPER CORP ORDINARY SHARES CANADA’s float is 0.04%. It closed at $6.3299 lastly. It is down 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Ero Copper Corp., a base metals mining company, engages in the production and sale of copper. The company has market cap of $436.21 million. The firm also explores for gold and silver ores. It has a 18.62 P/E ratio. It holds interests in the Vale do Curaçá property located in northeastern Bahia State, Brazil; and the Boa Esperança Property consists of a mineral concession covering an area of 4,034 hectares located in southeastern Pará State, Brazil.

Investors sentiment increased to 1.15 in Q4 2017. Its up 0.24, from 0.91 in 2017Q3. It increased, as 5 investors sold Amphastar Pharmaceuticals, Inc. shares while 36 reduced holdings. 16 funds opened positions while 31 raised stakes. 20.28 million shares or 1.20% more from 20.04 million shares in 2017Q3 were reported. Moreover, Principal Group Inc Inc has 0% invested in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) for 267,639 shares. Teacher Retirement System Of Texas invested 0% of its portfolio in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). Meeder Asset stated it has 0% of its portfolio in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). Teachers Retirement Of The State Of Kentucky accumulated 0% or 7,800 shares. Argent Capital Mgmt Llc reported 229,740 shares. Texas Permanent School Fund holds 0.01% or 23,931 shares in its portfolio. Morgan Stanley holds 128,203 shares or 0% of its portfolio. Assetmark reported 11 shares. Comerica Financial Bank owns 36,536 shares for 0% of their portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) invested 0% in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). Sei Investments Co accumulated 67,175 shares. Dekabank Deutsche Girozentrale has invested 0% of its portfolio in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). Northern Corp has invested 0% of its portfolio in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). Winslow Evans & Crocker reported 1,758 shares stake. Millennium Mngmt Lc has 293,672 shares.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.